A mural in Rome depicts a white dove parachuting vials of COVID-19 vaccine. Several COVID-19 vaccines are based on a viral vector developed by Canadian Frank Graham decades ago.
(AP Photo/Gregorio Borgia)
Viral vectors are modified viruses that trigger an immune response without causing infection. The vector that’s used in several COVID-19 vaccines was created decades ago by Canadian Frank Graham.
Voluntary modifications to behaviour – such as mask wearing when it’s not mandatory – are probably helping to keep the virus in check.
Social distancing has shielded us from other respiratory viruses – but that’s not necessarily a good thing.
Modelling suggested Sydney would open up when NSW had around 1,900 new daily cases. Last Monday, it eased restrictions with just 496 new cases.
The ongoing pandemic has accelerated and deepened our dependency on internet technologies.
The COVID-19 pandemic has meant an increased dependence on digital technologies. However, this comes with a serious threat to our personal privacy and property.
The average wellbeing of people with depression in Denmark improved over the first six months of the pandemic.
Although some youth are clearly reporting a negative effect on their social, personal and educational lives during the pandemic, the majority are responding to COVID-19 in ways that are developmentally and psychologically normal.
Is there a mental health crisis among young people, or are worry and sadness to be expected? Pathologizing normal, healthy responses to adverse events promotes misunderstanding about mental illness.
On Weibo, a Twitter-like social media website in China, feminists created hashtags such as “#她能” (#SheCan), “#看见女性劳动者” (#SeeingWomenWorkers) with the aim of helping women feel empowered.
Feminists across China came together on Weibo to fight back against under- and misrepresentation of them during the early days of COVID-19.
Firefighters conducting disinfection at the Terminal 3 of Wuhan Tianhe International Airport.
Xinhua / Alamy Stock Photo
Countries are transitioning from zero-COVID to vaccine-led strategies.
Consumers are still finding bare store shelves.
AP Photo/David Zalubowski
An expert on global supply chains explains why shortages of many products have persisted throughout the pandemic.
Korean Central News Agency/EPA-EFE
Kim Jong-un is simultaneously projecting different images domestically and internationally as food shortages and economic hardship rise.
In Montréal, people protested the Québec government’s measures to help stop the spread of COVID-19.
(The Canadian Press/Graham Hughes)
People who oppose vaccination won’t be swayed by statistics. To convince them, it is necessary to share real-life experiences and stories with which they will identify.
Home may have become associated with safety and control during lockdown, so resuming life in public can seem daunting.
Basilico Studio Stock/Shutterstock
The reason for these results has yet to be confirmed – but maths may explain the phenomenon.
The threat of disease changes how people behave to minimise the risk of infection – and can even influence their political preferences.
But the immune cells that vaccination spurs do last a long time.
An anti-vaccine protester and a vaccine supporter demonstrate in from of a Montréal hospital in September, 2021.
THE CANADIAN PRESS/Paul Chiasson
Trust is needed to curb vaccine hesitancy. Governments need to explain vaccines and other public health measures, while also speaking to the broader purpose of caring for the community we belong to.
BIANCA DE MARCHI/AAP
At the pool, the most likely place to catch COVID-19 is in the change rooms.
Afrofuturist’s work is rooted in the desire to transform the present for Black people. Here actor Mouna Traoré in ‘Brown Girl Begins’ (2017) directed by Sharon Lewis set in a post-apocalyptic version of Toronto.
Afrofuturist’s work is rooted in the desire to transform the present for Black people. To do so, they imagine a reality in which Black people are the agents of their own story, countering histories that discount and dismiss them.
Merck & Co/AP/AAP
Merck announced preliminary data suggesting the drug reduced the risk of hospitalisation and death by 50%.